| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| March 17, 2015 | CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 50,000 | -- | 216,664 | |
| September 20, 2012 | Director | Form 4 | Exercise of in-the-money or at-the-money derivative security | 35,000 | $2.72 | 219,911 | |
| February 25, 2011 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 50,000 | $2.49 | 219,911 | |
| June 12, 2013 | CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 10,000 | $1.35 | 223,285 | |
| March 17, 2015 | CMO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 50,000 | -- | 225,550 | |
| August 16, 2013 | CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 5,000 | $1.08 | 228,285 | |
| March 15, 2024 | Director, Executive Chairman of Board | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 12,500 | -- | 228,346 | |
| November 17, 2005 | EVP, CFO | Form 4/A | Open market or private purchase of non-derivative or derivative security | 21,300 | $0.29 | 231,667 | |
| July 8, 2011 | Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 75,000 | $3.46 | 232,009 | |
| July 25, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 46,838 | $4.27 | 243,942 | |
| June 15, 2012 | SVP - IR/PR | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 36,250 | $2.15 | 245,000 | |
| February 27, 2012 | CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 13,750 | -- | 245,759 | |
| May 6, 2013 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 45,000 | -- | 248,245 | |
| February 22, 2012 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 35,000 | -- | 254,911 | |
| February 25, 2011 | CMO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 70,000 | $2.49 | 255,000 | |
| August 9, 2011 | Director | Form 4 | Conversion of derivative security | 17,083 | $2.40 | 261,025 | |
| February 22, 2012 | CMO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 13,750 | -- | 268,750 | |
| February 2, 2016 | CMO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 50,000 | -- | 275,550 | |
| February 2, 2016 | CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- | 276,664 | |
| June 15, 2012 | CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 36,250 | $2.15 | 282,009 | |
| September 20, 2012 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 35,000 | $2.72 | 296,025 | |
| May 6, 2013 | SVP Investor Relations | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 80,000 | -- | 300,000 | |
| February 22, 2005 | VP, General Counsel | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 100,000 | -- | 300,000 | |
| June 13, 2022 | Director, Chairman, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 90,000 | -- | 303,068 | |
| February 11, 2014 | Director, CEO | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 44,444 | -- | 303,329 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.
